Skip to content
Vaporox Inc. logo — Revolutionizing Wound Care Through the Power of Vaporous Hyp...

Vaporox Inc.

Revolutionizing Wound Care Through the Power of Vaporous Hyperoxia Therapy (VHT™)

Founded 2016 United States Denver, United States 18 employees Series A Total: $9.68M Health Care, Medical Devices

General Information

Company Name Vaporox Inc.
Founded Year 2016
Location United States Denver, United States
Employees 18
Industries Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Vaporox Inc.. To contact Vaporox Inc., visit vaporox.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vaporox Inc. compare?

A PDF of Vaporox Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vaporox Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vaporox Inc.

Vaporox Inc. is a health care startup founded in 2016, headquartered in the United States. The company's slogan, "Breakthrough technology for treating skin wounds," encapsulates its focus on addressing the significant challenge of non-healing skin wounds which impose substantial costs and human suffering. For instance, diabetic foot ulcers (DFUs) alone result in 108,000 lower limb amputations annually in the U.S., with estimated economic costs of $14.8 billion/year. Vaporox, Inc. has developed Vaporous Hyperoxia Therapy (VHT™), a new, patented, and FDA-510K-cleared technology capable of treating 7 different types of skin wounds. The technology, which utilizes ultrasonic waves to create microscopic particles containing water and an anti-microbial, has demonstrated substantial efficacy through real-world data from observational studies. Impressively, VHT has healed 90.7% of DFUs that had previously resisted standard wound care treatment, while also reducing costs compared to less-effective methods. Looking ahead, Vaporox is gearing up to commence a new round of field trials focused on healing DFUs and pressure ulcers in early 2019. The company's progress has attracted substantial investment, with a $2.00M Series A investment received on 01 August 2022. Overall, Vaporox Inc. is positioned at the forefront of advancing wound care technology, offering a compelling solution to a pressing health challenge with noteworthy potential for both financial return and societal impact.

Business keywords: Medical Technology, Wound Healing, Vaporous Hyperoxia Therapy, Healthcare Innovation, Diabetic Foot Ulcers, Pressure Ulcers, FDA-510K-cleared, Observational Studies, Field Trials, Ultrasonic Waves, Microscopic Particles, Antimicrobial Technology, Patient Comfort, Chronic Wound Treatment, Healthcare Cost Reduction

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $2.00M -
01 Aug 2022
Corporate Round $4.93M 1
Bioventus
24 Jun 2021
Seed Round $776.99K 1
Lateral Capital
01 Apr 2020
Seed Round $1.50M 1
Rockies Venture Club
01 Sep 2019
Seed Round $470.00K 1
Rockies Venture Club
29 Mar 2019

Vaporox Inc. Alternatives & Competitors

View All Alternatives
Vaporox Inc. vs
AOTI
AOTI United States

Helping all people with chronic conditions get back to living their lives to the fullest.

Corporate Round
124 employees
Health Care, Medical Devices
Vaporox Inc. vs
Piomic Medical
Piomic Medical Switzerland

Advanced wound care, made personal.

Series A
17 employees
Health Care, Health and Wellness
Vaporox Inc. vs
DEBx Medical
DEBx Medical The Netherlands

Innovating the future of wound care

Private Equity
11 employees
Health Care, Medical Devices

FAQ About Vaporox Inc.

Revolutionizing Wound Care Through the Power of Vaporous Hyperoxia Therapy (VHT™)
Vaporox Inc. was founded in 2016.
Vaporox Inc. is headquartered in Denver, United States.
Vaporox Inc. operates in Health Care and Medical Devices. Its work centres on Medical Technology, Wound Healing, Vaporous Hyperoxia Therapy and Healthcare Innovation.
Vaporox Inc. has approximately 18 employees.
Vaporox Inc. has completed 5 funding rounds, raising a total of $9.68M. The latest funding stage is Series A.
Top alternatives and competitors to Vaporox Inc. include AOTI, Piomic Medical, DEBx Medical, ivWatch, LLC, Healthy.io. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaporox Inc. and AOTI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vaporox Inc., https://bouncewatch.com/company/vaporox-inc, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout